DR. PETER S. HAMMERMAN, MD, PHD
Osteopathic Medicine at Brookline Ave, Boston, MA

License number
Massachusetts 234745
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
450 Brookline Ave, Boston, MA 02215
Phone
(617) 632-3000

Personal information

See more information about PETER S. HAMMERMAN at radaris.com
Name
Address
Phone
Peter Hammerman, age 47
217 Greenwood St, Newton Center, MA 02459
(617) 524-0575
Peter Hammerman
Jamaica Plain, MA
(617) 524-0575

Professional information

See more information about PETER S. HAMMERMAN at trustoria.com
Peter S Hammerman Photo 1
Dr. Peter S Hammerman, Boston MA - MD (Doctor of Medicine)

Dr. Peter S Hammerman, Boston MA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Age:
46
Address:
Dana Farber Cancer Institute
450 Brookline Ave SUITE D1230, Boston 02215
(617) 632-1914 (Phone)
Boston Office
450 Brookline Ave, Boston 02215
(617) 632-3000 (Phone)
Certifications:
Internal Medicine, 2009, Medical Oncology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 2003
Massachusetts General Hospital


Peter S Hammerman Photo 2
Peter S Hammerman, Boston MA

Peter S Hammerman, Boston MA

Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215 Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115 Binney Medical Associates
1153 Centre St, Jamaica Plain, MA 02130 Binney Medical Associates
20 Prospect St, Milford, MA 01757 Dana Farber Cancer
40 Buttrick Rd, Londonderry, NH 03053 Binney Medical Associates
101 Columbian St, South Weymouth, MA 02190
Education:
University of Pennsylvania(2005)


Peter Hammerman Photo 3
Ddr2 Mutations In Squamous Cell Lung Cancer

Ddr2 Mutations In Squamous Cell Lung Cancer

US Patent:
2013026, Oct 3, 2013
Filed:
May 1, 2013
Appl. No.:
13/875079
Inventors:
Peter Hammerman - Jamaica Plain MA, US
Alexis Ramos - Somerville MA, US
International Classification:
C12Q 1/68
US Classification:
506 9, 435 612, 435 611
Abstract:
Methods for treating patients with squamous cell lung cancer, including detecting the presence of mutations in the discoidin domain receptor 2 (DDR2) gene.